# Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

> **NCT00477334** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 463 (actual)

## Conditions studied

- Genital Herpes

## Interventions

- **DRUG:** Famciclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00477334
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 463 (ACTUAL)
- **Last updated:** 2011-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477334, "Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00477334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*